Objective: Patients using a removable prosthesis are susceptible to a variety of oral lesions that may progress to cancer. Toluidine blue (TB) staining is used to identify premalignant lesions, but the results are still controversial. Since micronuclei (MN) are a biomarker of genetic instability, the objective of this study was to determine the frequency of MN in white lesions of the oral mucosa and to compare the results with those of the TB test. Study Design: The study included 20 removable prosthesis users with white lesions that were previously classified as toluidine positive or negative. The frequency of MN was evaluated in exfoliated cells from lesions and normal mucosa. Nuclear anomalies were also registered. Results: A significant increase (p < 0.05) in the frequency of MN was observed in exfoliated cells from lesions compared to normal mucosal cells, and no relationship was seen with TB staining. Lifestyle factors or gender did not influence the results. Conclusions: The frequency of MN is a sensitive biomarker and can be used to predict genomic instability in white oral lesions. The MN assay may serve as a good parameter in the battery of tests used to identify high-risk individuals, contributing to the identification of the biological conditions of oral lesions.

Keywords:
Dental patients, Removable prosthesis, Oral lesions, Exfoliated cells, Micronucleus, Toluidine blue
1.
Kamboj M, Mahajan S: Micronucleus – an upcoming marker of genotoxic damage. Clin Oral Invest 2007;11:121–126.
2.
Krahl D, Altenburg A, Zouboulis CC: Reactive hyperplasias, precancerous and malignant lesions of the oral mucosa. J Dtsch Dermatol Ges 2008;6:217–232.
3.
Kramer ER, Lucas RB, Pindborg JJ, Sobin LA: Definition of leucoplakia and related lesions: an aid to studies on oral pre-cancer. Oral Surg Oral Med Oral Pathol 1978;46:518–539.
4.
Lee JJ, Hung HC, Cheng SJ, Chen YJ, Chiang CP, Liu BY, Jeng JH, Chang HH, Kuo YS, Lan WH, Kok SH: Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:472–480.
5.
Neville BW, Day TA: Oral cancer and precancerous lesions. Cancer J Clin 2002;52:195–215.
6.
Saran R, Tiwari RK, Reddy PP, Ahuja YR: Risk assessment of oral cancer in patients with pre-cancerous states of the oral cavity using micronucleus test and challenge assay. Oral Oncol 2007;44:354–360.
7.
Instituto Nacional do Cancer. http://.inca.gov.br/estimative/2008/index.asp?link=tabelaestados.asp&UF=BR (accessed March 11, 2008).
8.
Department of Health: Cancer Registry Annual Report in Taiwan Area – 2003. Taipei, Department of Health, 2005.
9.
Bueno SF: Comparative study of the effectiveness of toluidine blue as a marker of areas for biopsy in oral mucosal white lesions; thesis, Faculdade de Odontologia de São Paulo, Ribeirão Preto, 1999, p 67.
10.
Onofre MA, Sposto MR, Navarro CM: Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:535–540.
11.
Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M: Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:45–50.
12.
Ribeiro DA, Angelieri F: Cytogenetic biomonitoring of oral mucosa cells from adults exposed to dental X-rays. Radiat Med 2008;25:325–330.
13.
Furrer VE, Benitez MB, Furnes M, Lanfranchi HE, Modesti MN: Biopsy vs superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J Oral Pathol Med 2006;35:338–444.
14.
Ramirez A, Saldanha PH: Micronucleus investigation of alcoholic patients with oral carcinoma. Genet Mol Res 2002;1:246–260.
15.
Kumar V, Rao NN, Nair SN: Micronuclei in oral squamous cell carcinoma. A marker of genotoxic damage. Indian J Dent Res 2000;11:101–116.
16.
Zalacain M, Sierrasesumaga L, Patino A: The cytogenetic assay as a measure of genetic instability induced by genotoxic agents. An Sist Sanit Navar 2005;28:227–236.
17.
Titenko-Holland N, Levine AJ, Smith MT, Quitana PJ, Boeninger M, Hayes R, Suruda A, Schulte P: Quantification of epithelial cell micronuclei by fluorescence in situ hybridization (FISH) in mortuary science students exposed to formaldehyde. Mutat Res 1996;371:237–248.
18.
Neri M, Fucic A, Knudsen LE, Lando C, Merlo F, Bonassi S: Micronuclei frequency in children exposed to environmental mutagens: a review. Mutat Res 2003;544:243–254.
19.
Hagmar L, Bonassi S, Stomberg U, Brogger A, Knudsen LE, Norppa H, Reuterwall C: Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 1998;58:4117–4121.
20.
Martins RA, Silva Gomes GA, Aguiar O Jr, Ribeiro D: Biomonitoring of oral epithelial cells in petrol station attendants: comparison between buccal mucosa and lateral border of the tongue. Environ Int 2009;35:1062–1065.
21.
Mashberg A: Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III. Cancer 1980;46:758–763.
22.
Sarto F, Tomarin R, Giacomelli L, Canova S, Raimondi F, Ghiotto G, Fiorentino MV: Evaluation of chromosomal aberrations in lymphocytes, oral mucosa and hair root cells of patients under antiblastic therapy. Mutat Res 1990;228:157–169.
23.
Stich HF, Rosin MP: Micronuclei in exfoliated cells as a tool for studies in cancer risk and cancer intervention. Cancer Lett 1984;22:241–253.
24.
Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, Knasmueller S, Fenech M: The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps. Mutat Res 2008;659:93–108.
25.
Cohen SM, Ellwein LB: Cell proliferation in carcinogenesis. Science 1990;249:1007–1011.
26.
Bloching M, Holfmann A, Lautenschlager C, Berghaus A, Grummt T: Exfoliative cytology of normal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay. Oral Oncol 2000;36:550–555.
27.
Carrard CV, Costa HC, Ferreira AL, Lauxen SI, Rados VP: Micronucleus assay – a biomarker of genotoxic damage in exfoliated oral mucosa cells. Rev Fac Odontol Porto Alegre 2007;48:77–81.
28.
Goiato MC, Castelleoni L, Santos DM, Gennari Filho H, Assunção WG: Oral injuries caused by the usage of removable prosthesis. Pesq Bras Odontol Clin Integr 2005;5:85–90.
29.
Missamann M, Jank S, Laimer K, Gassner R: A reason for the use of toluidine blue staining in the presurgical management of patients with oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:741–743.
30.
Sunila T, Anita B: Oral cancers – a two year survey. J Indian Acad Oral Med Radiol 2003;15:3–9.
31.
He JL, Chen LF, Jin HY: Comparative evaluation of the in vitro micronucleus test and the comet assay for the detection of genotoxic effects of X-ray radiation. Mutat Res 2000;469:223–231.
32.
Chatterjee S, Dhar S, Sengupta B, Ghosh A, De M, Roy S, Chowdhury RR, Chakrabarti S: Cytogenetic monitoring in human oral cancers and other oral pathology: the micronucleus test in exfoliated buccal cells. Toxicol Mech Meth 2009;19:427–433.
33.
Burzlaff JB, Bohrer PL, Paiva RL, Visioli F, Sant’Ana Filho M, Da Silva VD, Rados PV: Exposure to alcohol or tobacco affects the pattern of maturation in oral mucosal cells: a cytohistological study. Cytopathology 2007;18:367–375.
34.
Ergene S, Elik AC, Cavas T, Kaya F: Genotoxic biomonitoring study of population residing in pesticide contaminated regions in Göksu Delta: micronucleus, chromosomal aberrations and sister chromatid exchanges. Environ Int 2007;33:877–885.
35.
Fenech M: Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 2002;22:1128–1137.
36.
Reis RSA, Sadigursky M, Andrade MGS, Soares LP, Santo ARE, Bôas DSV: Genotoxic effect of ethanol on oral mucosa cells. Pesqui Odontol Bras 2002;16:221–225.
37.
Martins FK, Filho JB: Determinação da frequência de micronúcleos e outras alterações nucleares em células da mucosa bucal de indivíduos fumantes e não fumantes. Rev Fac Ciên Méd Sorocaba 2003;5:43–53.
38.
Tolbert PE, Shy JW: Micronuclei and other nuclear anomalies in buccal smears methods development. Mutat Res 1992;271:69–77.
39.
Kawashimaa K, Doib H, Itoa Y, Shibata M, Yoshinakaa R, Otsukia Y: Evaluation of cell death and proliferation in psoriatic epidermis. J Dermatol Sci 2004;35:17–23.
40.
Miller ML, Andringa A, Dixon K, Carty MP: Insights into UV-induced apoptosis: ultrastructure, trichrome stain and spectral imaging. Micron 2002;33:157–166.
41.
Roy M, Chakrabarty S, Sinha D, Bhattacharya RK, Siddiqi M: Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol. Mutat Res 2003;524:33–41.
42.
Saran R, Tiwari RK, Reddy PP, Ahuja YR: Risk assessment of oral cancer in patients with pre-cancerous states of the oral cavity using micronucleus test and challenge assay. Oral Oncol 2008;44:716–717.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.